SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Hotter-than-expected inflation has fueled concern about further Fed rate hikes, weighing on rate-sensitive Nasdaq stocks; traders also point to worries about AI spending and financing as amplifying the tech selloff. The community is split between calling it a broader AI-driven correction and looking for an oversold bounce, with upcoming economic data and TSMC results seen as potential catalysts.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A broad selloff in SPY has traders focused on hotter-than-expected inflation and the risk of a more hawkish Fed, with AI-sector worries adding to pressure. Bears see room for further declines, while some traders argue the drop is overdone and expect a relief bounce; upcoming PPI is another focus.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Gartners warning that most independent neocloud providers may not survive as AI infrastructure spending outpaces revenue has intensified concerns about CoreWeaves debt-heavy expansion and sharply rising bond yields. Traders are debating whether financing risks threaten the business or whether its large contract backlog and continuing AI demand make the selloff overdone.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is falling with neocloud and AI infrastructure stocks as traders react to Gartners warning that most independent neocloud providers may not remain independent by 2030, alongside concerns about financing costs and hot inflation. The selloff has sparked debate between investors viewing it as a sector-wide valuation reset and dip-buying opportunity, and those worried that capital-intensive AI buildouts may outpace returns.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Hotter-than-expected U.S. inflation and higher-rate concerns are weighing on NVDA alongside a broader tech and semiconductor selloff; traders are also questioning whether AI spending can justify valuations, citing debt-financed neocloud customers and potential circular financing. Bearish traders expect further weakness, while dip-buyers argue that AI-chip demand remains strong and view the pullback as an opportunity.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles steep selloff is drawing attention amid a broader AI-infrastructure downturn, with traders citing hotter-than-expected inflation and rate concerns alongside worries about Oracles heavy data-center spending, debt and exposure to AI customers. Some see the drop as an overreaction and are buying the dip, while others expect further downside as financing and demand risks persist.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor selloff has weighed on SOXL amid fears about Chinese chip competition, AI spending and profitability, and inflation; the funds 3x leverage is amplifying the swings. Traders disagree on whether the decline is an overreaction to strong chip demand or a sign of further downside, with dip-buyers facing off against bearish sellers.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is selling off with other neocloud and AI data-center stocks as traders react to Gartners warning that infrastructure spending may outpace AI revenue, alongside inflation and financing concerns. Bulls view the decline as a buying opportunity, while bears question the sectors economics; speculation about Anthropic-related news is also circulating.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

The FDA expanded Anktivas use to include BCG-unresponsive, high-grade papillary-only bladder cancer, broadening the eligible patient population ahead of the expected decision date. Traders generally view the label expansion as a meaningful commercial and regulatory positive, but many are frustrated by the muted share-price reaction and debate whether the approval was already priced in or the stock is facing selling pressure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

A sharp selloff across memory and AI-linked chip stocks has put MU in focus, with traders citing hotter inflation and rate concerns, doubts about AI spending and profitability, profit-taking, and competitive pressure from Chinas CXMT. Bulls argue that strong AI-memory demand and Microns fundamentals remain intact, while bears see the decline as part of a broader unwind of the AI trade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HUTCHMED (China) Reports H1 2026 Results: Full Earnings Call Transcript

HUTCHMED (China) (NASDAQ:HCM) released quarterly financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...

AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success

AstraZeneca halts a phase III NSCLC study for volrustomig after data show that the regimen is unlikely to meet key survival goals, while other lung cancer trials shine.

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating...

HUTCHMED (NASDAQ:HCM) Hits New 52-Week Low  - What's Next?

HUTCHMED (NASDAQ:HCM) Hits New 12-Month Low - What's Next...

HUTCHMED Highlights $1.4B Liquidity, 2026 Revenue Outlook, and SAFFRON Catalyst at DB Conference

HUTCHMED (NASDAQ:HCM) executives highlighted 2025 financial results, commercial momentum for its marketed oncology portfolio, and upcoming clinical and regulatory catalysts during a presentation at...

HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's Why

HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's Why...

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Rating of "Hold" by Analysts

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) has been given an average rating of "Hold" by the six ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold...

Short Interest in HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Decreases By 13.7%

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) saw a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 278,317 shares, a decrease of 13.7% from the February 26th total of 322,619 shares. Currently, 0.2% of the...

HUTCHMED (NASDAQ:HCM) Shares Gap Up   - Time to Buy?

HUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy...

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Brokerages

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) has been given a consensus rating of "Hold" by the six ratings firms that are presently covering the stock, Marketbeat Ratings...

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

HUTCHMED (China) Limited - ADR

Hutchmed Stock Hits Over One-Month High After China Accepts Kidney Cancer NDA Filed With Partner Innovent Biologics

Equity

Neutral Sentiment

Hotter than expected

As expected

Cooler than expected

The September Producer Price Index report lands Thursday, October 15 at 8:30 AM ET, one day after CPI, with August’s reading at 5.4% year over year, as investors look for clues on inflation before the Fed’s October 27-28 meeting. How will the September PPI print compare to consensus expectations? Vote and explain your reasoning in the comments.

How will the September PPI print compare to consensus expectations?

Current Price	$13.48
Prev Close	$13.50
Open	$13.51
Dividend Yield	0.00%
50-Day Moving Average	$13.21
Beta	0.89
Avg. Volume	92,153.16
PE Ratio	132.74

52-Week High	$16.33
52-Week Low	$9.77
Market Capitalization	$2.36B
EPS (Annual)	$2.62
Price to Book	1.87
Revenue Per Employee	$306,215.29

Feed

News

Sentiment

Earnings

Fundamentals

Info

HCM Fundamentals